• Typhoid conjugate vaccine 81% effective among kids in phase 3 trial

    7 monthes ago - By Healio

    A single-dose typhoid conjugate vaccine effectively reduced typhoid in children aged 9 months to 16 years by more than 81% during a phase 3 trial in Nepal, according to results published in The New England Journal of Medicine.
    “The data from this study give confidence that the new typhoid conjugate vaccine could have a major impact on this disease and improve the health of some of the most vulnerable children in the world,” Andrew J. Pollard, FRCPCH, PhD, FMedSci, professor of pediatric infection and immunity at the University of Oxford, told Healio. “We were delighted
    Read more ...